BeOne Medicines
ONC
#650
Rank
โ‚น3.240 T
Marketcap
โ‚น29,287
Share price
0.71%
Change (1 day)
66.61%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Revenue for BeOne Medicines (ONC)

Revenue in 2025 (TTM): โ‚น430.45 Billion

According to BeOne Medicines's latest financial reports the company's current revenue (TTM ) is โ‚น447.82 Billion. In 2024 the company made a revenue of โ‚น326.86 Billion an increase over the revenue in the year 2023 that were of โ‚น204.69 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for BeOne Medicines from 2015 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น430.45 B31.69%
2024 โ‚น326.86 B59.69%
2023 โ‚น204.69 B74.7%
2022 โ‚น117.16 B33.83%
2021 โ‚น87.55 B287.58%
2020 โ‚น22.58 B-26.02%
2019 โ‚น30.53 B120.32%
2018 โ‚น13.86 B-8.94%
2017 โ‚น15.22 B20833.65%
2016 โ‚น72.71 M-87.59%
2015 โ‚น0.58 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Onconova Therapeutics
ONTX
โ‚น20.35 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
โ‚น57.82 B-87.09%๐Ÿ‡บ๐Ÿ‡ธ USA